| |
 |
|
Class Information
Number: 514/834
Name: Drug, bio-affecting and body treating compositions > Coagulant
Description: Subject matter involving the enhancing of coagulation.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7291333 |
Blockade of protein C activation reduces microvascular surgical blood loss |
Nov. 6, 2007 |
| 7271143 |
Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy |
Sep. 18, 2007 |
| 7268110 |
Agents for preventing and treating thrombocytopenia |
Sep. 11, 2007 |
| 7101557 |
Combined tissue factor methods for coagulation and tumor treatment |
Sep. 5, 2006 |
| RE39150 |
Composition for creating vascular occlusions |
Jun. 27, 2006 |
| 7041635 |
Factor VIII polypeptide |
May. 9, 2006 |
| 7033994 |
Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
Apr. 25, 2006 |
| 7015193 |
Compositions and methods to control bleeding |
Mar. 21, 2006 |
| 6956022 |
Agents for preventing and treating thrombocytopenia |
Oct. 18, 2005 |
| 6930087 |
Pharmaceutical composition comprising factor VIII and neutral liposomes |
Aug. 16, 2005 |
| 6903069 |
Factor VII glycoforms |
Jun. 7, 2005 |
| 6884616 |
DNA-construct for the tissue-specific expression of a blood coagulation factor |
Apr. 26, 2005 |
| 6855734 |
Glycine betaine and its use |
Feb. 15, 2005 |
| 6833352 |
Coagulation factor Viia composition |
Dec. 21, 2004 |
| 6797260 |
Bleeding control and healing aid compositions and methods of use |
Sep. 28, 2004 |
| 6783774 |
Substance that stop any kind of bleeding within one second for medical, surgical, postsurgical and dental uses |
Aug. 31, 2004 |
| 6780614 |
Modified factor VIII cDNA and its use for the production of factor VIII |
Aug. 24, 2004 |
| 6652840 |
Bleeding control and healing aid compositions and methods of use |
Nov. 25, 2003 |
| 6593294 |
Pharmaceutical composition comprising Factor VIII and neutral liposomes |
Jul. 15, 2003 |
| 6559133 |
Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes |
May. 6, 2003 |
| 6521265 |
Method for applying a blood clotting agent |
Feb. 18, 2003 |
| 6458563 |
Modified factor VIII |
Oct. 1, 2002 |
| 6403556 |
Pharmaceutical preparation containing protein C and a thrombolytically active substance |
Jun. 11, 2002 |
| 6391343 |
Fibrinogen-coated particles for therapeutic use |
May. 21, 2002 |
| 6346513 |
Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
Feb. 12, 2002 |
| 6264988 |
Fibrinogen-coated microspheres |
Jul. 24, 2001 |
| 6228613 |
Stable factor VIII/von Willebrand factor complex |
May. 8, 2001 |
| 6132730 |
Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment |
Oct. 17, 2000 |
| 6132729 |
Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment |
Oct. 17, 2000 |
| 6130203 |
Hybrid proteins with modified activity |
Oct. 10, 2000 |
| 6110483 |
Adherent, flexible hydrogel and medicated coatings |
Aug. 29, 2000 |
| 6048720 |
Conjugates of a polypeptide and a biocompatible polymer |
Apr. 11, 2000 |
| 6037366 |
Composition for creating vascular occlusions |
Mar. 14, 2000 |
| 6013620 |
Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
Jan. 11, 2000 |
| 5919766 |
Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
Jul. 6, 1999 |
| 5914098 |
Aerosol composition for forming a hydrated membrane, and applications thereof |
Jun. 22, 1999 |
| 5910481 |
Hybrid proteins with modified activity |
Jun. 8, 1999 |
| 5897860 |
Method for controlling bleeding and microbial infections by administering thrombin, casein kinase II, and sphingosine |
Apr. 27, 1999 |
| 5891843 |
Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
Apr. 6, 1999 |
| 5888974 |
Hybrid human/animal factor VIII |
Mar. 30, 1999 |
| 5846567 |
Clot dissolving method |
Dec. 8, 1998 |
| 5837679 |
Agents affecting thrombosis and hemostasis |
Nov. 17, 1998 |
| 5830467 |
Pharmaceutical preparation containing protein C and a thrombolytically active substance |
Nov. 3, 1998 |
| 5733873 |
Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
Mar. 31, 1998 |
| 5726028 |
Method for detecting disturbances of the protein c/protein s system |
Mar. 10, 1998 |
| 5716795 |
Thrombomodulin-based coagulometric assay of the protein C system |
Feb. 10, 1998 |
| 5643739 |
Assay for determining sensitivity to activated protein C |
Jul. 1, 1997 |
| 5593968 |
Virus-inactivated factor Xa preparation |
Jan. 14, 1997 |
| 5576291 |
Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
Nov. 19, 1996 |
| 5552296 |
Method for the determination of coagulation parameters |
Sep. 3, 1996 |
|
|
|
